Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00038181Phase 2Completed
A Phase 2 trial of thalidomide in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00038181.